173 related articles for article (PubMed ID: 7271431)
1. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
Magdon E; Schröder E
Arch Geschwulstforsch; 1981; 51(3):225-30. PubMed ID: 7271431
[TBL] [Abstract][Full Text] [Related]
2. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
[TBL] [Abstract][Full Text] [Related]
3. [Tissue distribution of iso-metronidazole and metronidazole in tumor-bearing C3H inbred mice].
Magdon E; Amon I; Peters R; Schröder E
Arch Geschwulstforsch; 1985; 55(1):31-5. PubMed ID: 3985767
[TBL] [Abstract][Full Text] [Related]
4. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
Rockwell S; Irvin CG; Nierenburg M
Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
[TBL] [Abstract][Full Text] [Related]
5. [Radiosensitizing and toxic action of metronidazole and isometronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole) on the cells of Ehrlich ascites cancer and hemoblastosis La in vitro].
Proskuriakov SIa; Smoryzanova OA; Dedenkov AN; Riabchenko NI
Radiobiologiia; 1986; 26(6):766-70. PubMed ID: 3809411
[TBL] [Abstract][Full Text] [Related]
6. [The radiation sensitizing activity of metronidazole and iso-metronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole)].
Proskurjakov SJ; Smoryzanova OA; Rjabcenko NI; Dedenkov AN
Radiobiol Radiother (Berl); 1990; 31(6):531-6. PubMed ID: 2101458
[TBL] [Abstract][Full Text] [Related]
7. [Radiosensitizing and toxic effect of metronidazole and its ortho-isomer 1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole on Escherichia coli B/r cells].
Riabchenko NI; Petrova KM; Proskuriakov SIa
Radiobiologiia; 1985; 25(6):744-7. PubMed ID: 3909211
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 4-nitroimidazole (iso-metronidazole) on the radiation-induced growth retardation and therapeutic quotient of transplanted tumors].
Magdon E
Radiobiol Radiother (Berl); 1985; 26(3):351-8. PubMed ID: 4059521
[No Abstract] [Full Text] [Related]
9. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
10. Iodinated nitroimidazoles as radiosensitizers.
Krause W; Jordan A; Scholz R; Jimenez JL
Anticancer Res; 2005; 25(3B):2145-51. PubMed ID: 16158957
[TBL] [Abstract][Full Text] [Related]
11. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
[TBL] [Abstract][Full Text] [Related]
12. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
[No Abstract] [Full Text] [Related]
13. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro.
Skov KA; Farrell NP; Adomat H
Radiat Res; 1987 Nov; 112(2):273-82. PubMed ID: 3685256
[TBL] [Abstract][Full Text] [Related]
14. Effect of metronidazole on the radiocurability and oxygenation of the C3HBA tumor.
Haynes MJ; Inch WR
Radiat Res; 1976 Oct; 68(1):184-9. PubMed ID: 967973
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of isometronidazole. Basic model and estimation of the kinetic parameters from experimental data.
Hentschel M; Schmidt W
Pharmazie; 1992 Mar; 47(3):221-4. PubMed ID: 1615029
[TBL] [Abstract][Full Text] [Related]
16. Action of misonidazole on L5178Y-R and L5178Y-S cells. II. Cytotoxicity and radiosensitization under hypoxic conditions.
Niepokojczycka E; Szumiel I; Walicka M
Neoplasma; 1981; 28(4):435-40. PubMed ID: 7290267
[TBL] [Abstract][Full Text] [Related]
17. [The radiation-sensitizing effect of isometronidazole following its intravesical application in bladder carcinoma. A clinical phase-II study].
Kob D; Lilienthal A; Bauhardt H; Merkle K; Schröder E; Schröder E; Hentschel M
Strahlenther Onkol; 1991 Sep; 167(9):530-3. PubMed ID: 1925936
[TBL] [Abstract][Full Text] [Related]
18. [Combined effect of metronidazole, interferon synthesis inducers and DNA repair inhibitors].
Leonidze DL; Afanas'ev GG; Khanson KP; Vartanian LP; Poverennyĭ AM
Radiobiologiia; 1986; 26(2):231-5. PubMed ID: 3704119
[TBL] [Abstract][Full Text] [Related]
19. The role of radiosensitizing drugs in the management of cancer.
Adams GE
Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
